OMIC
BMY icon

Old Mission Investment Co’s Bristol-Myers Squibb BMY Stock Holding History

Old Mission Investment Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Sell
6,607
-4
-0.1% -$230 0.08% 103
2026
Q1 		$401K Buy
6,611
+510
+8% +$29.7K 0.09% 91
2025
Q4 		$329K Buy
6,101
+252
+4% +$12.1K 0.08% 98
2025
Q3 		$264K Sell
5,849
-2,951
-34% -$138K 0.06% 114
2025
Q2 		$407K Buy
8,800
+1,912
+28% +$93.9K 0.11% 94
2025
Q1 		$420K Buy
6,888
+37
+0.5% +$2.16K 0.13% 82
2024
Q4 		$387K Sell
6,851
-867
-11% -$48.4K 0.12% 89
2024
Q3 		$399K Sell
7,718
-468
-6% -$22K 0.12% 85
2024
Q2 		$340K Buy
8,186
+188
+2% +$8.41K 0.11% 92
2024
Q1 		$434K Sell
7,998
-152
-2% -$7.74K 0.14% 76
2023
Q4 		$418K Sell
8,150
-688
-8% -$36.1K 0.15% 78
2023
Q3 		$513K Buy
8,838
+912
+12% +$55.9K 0.2% 66
2023
Q2 		$507K Buy
7,926
+42
+0.5% +$2.82K 0.19% 68
2023
Q1 		$546K Sell
7,884
-18
-0.2% -$1.27K 0.21% 64
2022
Q4 		$569K Buy
7,902
+71
+0.9% +$5.35K 0.24% 61
2022
Q3 		$557K Sell
7,831
-191
-2% -$13.9K 0.26% 54
2022
Q2 		$618K Sell
8,022
-162
-2% -$12.3K 0.27% 53
2022
Q1 		$598K Sell
8,184
-91
-1% -$6.11K 0.22% 61
2021
Q4 		$516K Buy
8,275
+255
+3% +$15K 0.19% 71
2021
Q3 		$475K Buy
8,020
+175
+2% +$11.5K 0.19% 68
2021
Q2 		$524K Buy
7,845
+500
+7% +$32.6K 0.22% 69
2021
Q1 		$464K Buy
7,345
+1,445
+24% +$89.9K 0.22% 66
2020
Q4 		$366K Sell
5,900
-1,044
-15% -$64.2K 0.19% 69
2020
Q3 		$419K Buy
6,944
+793
+13% +$47.7K 0.25% 57
2020
Q2 		$362K Buy
6,151
+213
+4% +$12.7K 0.25% 54
2020
Q1 		$331K Buy
5,938
+803
+16% +$49.1K 0.31% 49
2019
Q4 		$330K Buy
5,135
+177
+4% +$10.1K 0.3% 51
2019
Q3 		$251K Buy
+4,958
New +$233K 0.24% 53

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Old Mission Investment Co's BMY Position: Q2 2026 in Review

Old Mission Investment Co reduced its Bristol-Myers Squibb (BMY) stake by 0.06% in Q2 2026, selling an estimated $230 and leaving 6,607 shares worth $381K. The position accounts for 0.08% of the portfolio, ranked #103.

Old Mission Investment Co first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $618K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Old Mission Investment Co held 6,607 shares of Bristol-Myers Squibb worth $381K as of Q2 2026.
  • Old Mission Investment Co sold 4 Bristol-Myers Squibb shares in Q2 2026, an estimated $230.
  • Bristol-Myers Squibb made up 0.08% of Old Mission Investment Co's portfolio in Q2 2026, its #103 holding.
  • Old Mission Investment Co first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
  • Old Mission Investment Co's Bristol-Myers Squibb position peaked at $618K in Q2 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Old Mission Investment Co's 13F filing for Q2 2026, filed 14 Aug 2026.